Table 1.
LV-GCA | Atherosclerosis | |
---|---|---|
No. of patients | 9 | 22 |
Age (years): mean (SD) | 67.4 (8.8) | 67.6 (7.0) |
Gender, no. female (%) | 6 (66.7) | 14 (63.6) |
No. of subjects on treatment with glucocorticoids/immunosuppression | 0 | 0 |
No. of subjects with C-GCA in the medical history | 4 suspected, 1 TAB proven (5–11 years before aortic surgery) | 0 |
ESR (mm/h): median (IQR)* | 12.5 (3.5–27.3) | 15 (4–20) |
CRP (mg/L): median (IQR)# | 9 (5–11) | 5 (5–11) |
Total length of studied aortic tissue (mm): median (IQR) | 64.7 (43.8–74) | 54.1 (46.1–63.4) |
Reported data is from the time of aorta surgery.
ESR; n = 6 for LV-GCA and n = 19 for atherosclerosis.
CRP; n = 7 for LV-GCA and n = 19 for atherosclerosis. There was no significant difference between the groups regarding age, gender, ESR, CRP, and the total length of studied aortic tissue.